BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 6574132)

  • 61. Enhancement of the incorporation of 5-fluorodeoxyuridylate into DNA of HL-60 cells by metabolic modulations.
    Tanaka M; Kimura K; Yoshida S
    Cancer Res; 1983 Nov; 43(11):5145-50. PubMed ID: 6225512
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A novel triple label method validates the double label technique of defining cell cycle kinetics in HL-60 cells.
    Mehdi A; Bokhari SA; Yousuf N; Umerani A; Chughtai S; Hussain F; Raza A
    Anticancer Res; 1992; 12(5):1443-6. PubMed ID: 1444205
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Control of lysozyme induction in the differentiation of myeloid leukemic cells.
    Krystosek A; Sachs L
    Cell; 1976 Dec; 9(4 PT 2):675-84. PubMed ID: 1017012
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Differentiation of human promyelocytic leukemia (HL-60) cells induced by new synthetic retinoids 4-(ethoxycarbophenyl) retinamide and 4-(hydroxycarbophenyl) retinamide].
    Song ZP; Liu YH; Han R
    Yao Xue Xue Bao; 1984 Aug; 19(8):576-81. PubMed ID: 6399190
    [No Abstract]   [Full Text] [Related]  

  • 65. Study of differentiation of fresh myelogenous leukemic cells by compounds that induce a human promyelocytic leukemic line (HL-60) to differentiate.
    Koeffler HP; Yelton L; Prokocimer M; Hirji K
    Leuk Res; 1985; 9(1):73-81. PubMed ID: 3857407
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Requirements for RNA and protein synthesis in the induction of several differentiation-markers in a myeloid leukemia cell line.
    Nagata K; Ichikawa Y
    J Cell Physiol; 1979 Jan; 98(1):167-75. PubMed ID: 283073
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Induction of HL-60 differentiation by starvation for a single essential amino acid but not by protein synthesis inhibitors.
    Pilz RB; Van den Berghe G; Boss GR
    J Clin Invest; 1987 Mar; 79(3):1006-9. PubMed ID: 3469216
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effects of dimaprit on growth and differentiation of human promyelocytic cell line, HL-60.
    Kalinyak KA; Sawutz DG; Lampkin BC; Johnson CL; Whitsett JA
    Life Sci; 1985 May; 36(20):1909-16. PubMed ID: 2985904
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The effect of 5-bromodeoxyuridine on interferon production in human cells.
    Baker PN; Bradshaw TK; Morser J; Burke DC
    J Gen Virol; 1979 Oct; 45(1):177-84. PubMed ID: 160442
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Interaction of monoclonal antibodies directed against bromodeoxyuridine with pyrimidine bases, nucleosides, and DNA.
    Miller MR; Heyneman C; Walker S; Ulrich RG
    J Immunol; 1986 Mar; 136(5):1791-5. PubMed ID: 3950402
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Mechanism of action of the synthetic imidazole compound YM 534 on human promyelocytic leukemia line HL-60 cells.
    Kanamaru R; Ishioka C; Konishi Y; Ishikawa A; Shibata H; Wakui A
    Anticancer Drug Des; 1989 Aug; 4(2):137-44. PubMed ID: 2803462
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Interaction of 2'-halogeno-2'-deoxyuridines with the human erythrocyte nucleoside transport mechanism.
    Gati WP; Knaus EE; Wiebe LI
    Mol Pharmacol; 1983 Jan; 23(1):146-52. PubMed ID: 6223203
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Differences in the incorporation of thymidine into DNA of normal and cystic fibrosis fibroblasts in vitro.
    Barranco SC; Bolton WE; Haenelt BR; Abell CW
    J Cell Physiol; 1976 May; 88(1):33-41. PubMed ID: 1262404
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Induction of terminal differentiation and nuclear appendage(s) formation in a human myeloid leukaemia cell line (HL-60).
    Mukherjee AB; Czirbik RJ; Parsa NZ; Testa JR
    Cytobios; 1985; 44(176):109-18. PubMed ID: 3867419
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Analysis of mutations in the thymidine kinase gene of varicella zoster virus associated with resistance to 5-iodo-2'-deoxyuridine and 5-bromo-2'-deoxyuridine.
    Kodama E; Mori S; Shigeta S
    Antiviral Res; 1995 May; 27(1-2):165-70. PubMed ID: 7486953
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Induction of differentiation of human myeloid leukemia HL-60 cells by novel pyrimidine nucleoside analogs.
    Makishima M; Honma Y; Hozumi M; Sampi K; Hattori M; Ishikawa I; Ogura H; Kawahara N; Kanaiwa T; Motoyoshi K
    Biochim Biophys Acta; 1991 Aug; 1094(1):1-7. PubMed ID: 1883847
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The effects of incorporation of 5-halogenated deoxyuridines into the DNA of eukaryotic cells.
    Goz B
    Pharmacol Rev; 1977 Dec; 29(4):249-72. PubMed ID: 364496
    [No Abstract]   [Full Text] [Related]  

  • 78. Immune system: maturation of myeloid cells.
    Ennaciri J; Girard D
    Methods Mol Biol; 2009; 550():195-203. PubMed ID: 19495705
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The BrdU content of DNA is decreased during reversal of inhibition of myogenesis by deoxycytidine.
    Wright WE
    Somatic Cell Genet; 1982 Sep; 8(5):547-55. PubMed ID: 7135161
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Thymidine kinase-deficient mutants of Aedes albopictus mosquito cells.
    Mazzacano CA; Fallon AM
    In Vitro Cell Dev Biol; 1992 Jun; 28A(6):455-8. PubMed ID: 1634444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.